Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 6;24(17):3161-3166.
doi: 10.1021/acs.orglett.2c00885. Epub 2022 Apr 26.

Boron NMR as a Method to Screen Natural Product Libraries for B-Containing Compounds

Affiliations

Boron NMR as a Method to Screen Natural Product Libraries for B-Containing Compounds

Jocelyn M Macho et al. Org Lett. .

Abstract

Natural products are biologically relevant metabolites exploited for biomedicine and biotechnology. The frequent reisolation of known natural products questions whether existing discovery models are still capable of identifying novel compounds. As innovative NMR-based screening techniques can help overcome these challenges, we applied a phase cycling composite pulse sequence to 11B NMR experiments to enhance their sensitivity to screen libraries for novel boron-containing molecules. Aplasmomycin and autoinducer-2 were detected in crude and enhanced microbial fractions, via their boron signals, as proof of concept. Subsequently, a screen of 21 crude plant and 50 crude marine microbial extracts were chosen at random and analyzed with the optimized 11B experiment for feasibility as a high throughput discovery method. Eight of the plant samples and 13 of the microbial samples were identified as boron-containing, suggesting that there is a higher presence of boron metabolites available from natural sources than previously known due to a lack of appropriate discovery methods. As a result, we believe that this optimized 11B NMR experiment can serve as a robust method for quick and facile discovery of novel boron-containing metabolites from a variety of natural sources.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Examples of boron-containing metabolites.
Figure 2
Figure 2
3.93 mM 5 in CD3OD, ns = 128, in borosilicate and quartz NMR tubes. The 11B proton decoupled experiment with the standard zgig pulse sequence in both borosilicate (a) and in quartz (b) tubes pick up extraneous probe noise from outside the NMR coil, causing large, asymmetrical peaks, which can overshadow compound peaks. Use of the zgbs pulse sequence with the proton decoupled 11B NMR in quartz tubes (c) is best for suppressing extraneous probe noise.
Figure 3
Figure 3
Structures of additional boronic compounds used to illustrate the effectiveness of the 11B NMR experiment with the applied pulse sequence.
Figure 4
Figure 4
3.22 mM of 6 in CDCl3 via the standard Bruker 11B decoupling NMR experiment in quartz NMR tubes (blue), ns = 128, yields the boron hump, overshadowing distinctive chemical signals. Application of the zgbs pulse sequence (red), ns = 128, eliminates background resonance noise allowing for clear identification of boron peaks.
Figure 5
Figure 5
11B NMR of 3.22 mM 6 in CDCl3 via the standard 11B proton decoupled experiment, ns = 128, throughout various stages of purification. Significant reduction of extraneous signals is observed with the pulse sequence resulting in clearly distinguishable boron peaks.
Figure 6
Figure 6
11Bzgbsig proton decoupled NMR of V. harveyi in D2O, ns = 512. Closer inspection of the peak reveals pentet splitting (insert) from the exchange between D2O and boron on 3, further proving detection of the molecule.
Figure 7
Figure 7
Percent distribution of boron found in the plant and microbial samples screened using the optimized 11B NMR experiment.

References

    1. Demain A. L. F. A.The Natural Functions of Secondary Metabolites. In History of Modern Biotechnology I. Advances in Biochemical Engineering/Biotechnology; Fiechter A., Ed.; Springer: Berlin, Heidelberg, 2000; Vol. 69. - PubMed
    1. Dias D. A.; Urban S.; Roessner U. A Historical Overview of Natural Products in Drug Discovery. Metabolites 2012, 2 (2), 303–336. 10.3390/metabo2020303. - DOI - PMC - PubMed
    1. Yan Y.; Liu Q.; Jacobsen S. E.; Tang Y. The impact and prospect of natural product discovery in agriculture: New technologies to explore the diversity of secondary metabolites in plants and microorganisms for applications in agriculture. EMBO Rep. 2018, 19 (11), e4682410.15252/embr.201846824. - DOI - PMC - PubMed
    1. Pye C. R.; Bertin M. J.; Lokey S.; Gerwick W. H.; Linington R. G. Retrospective analysis of natural products provides insights for future discovery trends. Proc. Natl. Acad. Sci. U.S.A. 2017, 114 (22), 5601–5606. 10.1073/pnas.1614680114. - DOI - PMC - PubMed
    1. Krause J. Applications and Restrictions of Integrated Genomic and Metabolomic Screening: An Accelerator for Drug Discovery from Actinomycetes?. Molecules 2021, 26 (18), 5450.10.3390/molecules26185450. - DOI - PMC - PubMed

Publication types